Skip to Main Content

Yale Pathology Legacy Tissue Donation: The Physician Perspective

December 07, 2022

Harry Sanchez, MD, Director of the Yale Pathology Legacy Tissue Donation Program, and Marcello DiStasio, MD, PhD, Co-Director, discuss the importance of tissue donation to cancer research.

ID
9238

Transcript

  • 00:04My name's Harry Sanchez.
  • 00:05I'm the director of the autopsy service,
  • 00:08and along with Marcello Destasio,
  • 00:10I'm the Co director of the
  • 00:13Yale legacy Tissue Donation
  • 00:15program. Very much like
  • 00:16organ donation programs,
  • 00:17people who become part of the
  • 00:20legacy tissue donation program help
  • 00:22address a pressing medical need.
  • 00:24By donating their tissue
  • 00:26after they pass away,
  • 00:27donors are providing cancer
  • 00:29researchers with invaluable
  • 00:30tissue that can't be obtained.
  • 00:32Any other
  • 00:33way, at any price.
  • 00:35Clinical scientists have
  • 00:36many avenues for research,
  • 00:38including animal models,
  • 00:39cell culture, surgical specimens
  • 00:40and standard autopsies.
  • 00:42But each of these has a limitation.
  • 00:45Tissues that patients donations
  • 00:46provide represent an invaluable
  • 00:48resource for us to understand
  • 00:50the exact mechanisms by which
  • 00:52diseases start and progress.
  • 00:54This program is
  • 00:55patient driven and completely reliant on
  • 00:58the incredible generosity of our donors,
  • 01:00a remarkable act of altruism.
  • 01:02As the power to advance our understanding
  • 01:04of cancer biology and the potential to
  • 01:06change the way we treat cancer, there's
  • 01:08no way we can thank you enough.